The FDA placed both peptides on its list of bulk drug substances that may not be compounded under Section 503A of the Federal Food, Drug, and Cosmetic Act in a 2023 proposed rule, citing insufficient evidence of clinical use and safety [13]
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as highly effective anti-obesity therapies, producing weight loss of approximately 520% across clinical trials
I would highly recommend doing these things
Then build from there, one meal at a time
Redness, itching, or mild irritation at the application site can occur, particularly during initial use or with higher concentrations
Diarrhea versus other retatrutide GI side effects Diarrhea does not exist in isolation